NFILTRATING gliomas are the most common primary tumors of the central nervous system in adults; nearly 17,000 gliomas are diagnosed annually in the US and carry a mortality rate approaching 80% within the 1st year after diagnosis. 3, 9, 30 Surgery remains the first-line treatment for these tumors and provides a tissue-based diagnosis that can be used to guide later therapies, including externalbeam radiation therapy and chemotherapy. Despite aggressive multimodal treatment approaches, gliomas recur and may undergo malignant progression. 16 Currently, postoperative MR imaging is typically performed within 24 hours after tumor resection and the findings serve as the new baseline for subsequent imaging studies. 24, 27 Evidence of tumor recurrence is based on the development of new contrast enhancement on subsequent imaging studies. New enhancement frequently results in significant changes in case management, including the addition of focal radiation therapies and enrollment of patients in experimental chemotherapy trials. The therapeutic benefits of these salvage therapies are then assessed by viewing subsequent images, with resolution of contrast enhancement deemed evidence of successful treatment and increased enhancement viewed as a treatment failure.
tients with gliomas remains to be defined, 7, 12, 14, 15, 19, 33, 34 and its role in the immediate postoperative period has not been previously reported.
As part of an ongoing prospective study designed to assess the role of multiple imaging modalities in the management of glioma, our group regularly performs diffusion-weighted imaging in patients with gliomas. We have frequently noted both cortical and subcortical nodular and fingerlike focal areas of reduced diffusion adjacent to the tumor resection cavity on MR images obtained immediately postoperatively. The significance of these imaging abnormalities has not been reported. In the present report we describe the occurrence of these lesions in a prospectively followed group of patients with low-or high-grade infiltrating gliomas. We show that as these areas of reduced diffusion resolve, the corresponding areas on later neuroimages demonstrates Gd enhancement, which subsequently regresses to form an area of encephalomalacia. Conventional MR imaging of this area during the period of Gd enhancement produces the appearance of a lesion that is indistinguishable from recurrent tumor. Without the benefit of postoperative diffusion-weighted sequences to aid in the interpretation of this enhancing area, the MR image may be misinterpreted as being a recurrent tumor. Consequently, the patient may be referred for aggressive new chemotherapy trials, and when the contrast enhancement resolves after one or more cycles of treatment, the clinician may erroneously declare that the chemotherapy was successful.
Clinical Material and Methods

Patient Population and Surgical Techniques
We prospectively studied 44 consecutive patients in whom infiltrating gliomas had been newly diagnosed (World Health Organization Grades II-IV) 17 who underwent preoperative, immediately postoperative, and subsequent follow-up MR imaging at our institution. Immediately postoperative imaging was typically performed within 48 hours after surgery, and the subsequent first and second follow-up imaging studies were typically performed within 2 months and between 2 and 4 months following surgery, respectively. For patients undergoing postoperative radiation therapy, follow-up imaging was first performed before radiation therapy and second after its completion. Additional follow-up images were also reviewed for patients in whom additional imaging studies were obtained. All patients underwent either gross-total or subtotal resection via corticectomy. The medical records of all 44 patients were reviewed and clinical and operative data associated with these persons were collected. Preoperative systolic blood pressure, the range of documented intraoperative systolic blood pressure, and the minimum intraoperative O 2 saturation were obtained from the anesthesia record. This review was conducted in accordance with the University of California, San Francisco Committee on Human Research (approved Protocol No. H40232-23679-01).
Tumor resection was performed using a Cavitron Ultrasonic Aspiration System (Valleylab, Boulder, CO). Hemostatic agents, including Surgicel (Ethicon Inc., Somerville, NJ) and Gelfoam (Upjohn Co., Kalamazoo, MI) were routinely used. The former was typically used to line the surgical cavity at the end of the procedure, whereas the latter was removed from the resection cavity prior to closure. It is routine at our institution for patients to receive postoperative steroid medications, typically dexamethasone 4 mg every 6 hours, with varied tapering schedules. It is also routine at our institution to ensure that anticonvulsant therapy (typically phenytoin and/or levetiracetam) is begun or continued in our patients during the immediate postoperative period.
Acquisition of MR Images
All neuroimaging studies were performed using a 1.5-tesla clinical MR imaging unit. All patients underwent two different MR imaging protocols, depending on whether neuroimaging was performed preoperatively or immediately postoperatively at follow up. Both protocols included the following sequences: 1) three-plane localizer (TR 24.9 msec, TE 1.6 msec, NEX 1); 2) sagittal T 1 -weighted imaging (TR 500 msec, TE 14 msec, NEX 1, section thickness 4 mm with a gap of 1 mm, FOV 22 ϫ 22 cm); 3) axial FLAIR imaging (TR 10,000 msec, TE 33 msec, TI 2200 msec, NEX 1, FOV 22 ϫ 22 cm, matrix 256 ϫ 192 pixels, section thickness 5 mm with no gap); and 4) diffusion-weighted imaging (single-shot echo-planar sequence; TR 10,000 msec, TE 101 msec, FOV 36 ϫ 36 cm, acquisition matrix 128 ϫ 128 pixels, section thickness 5 mm with no gap, diffusion gradients 0 and 1000 mm 2 /second, acquired in three orthogonal directions). The preoperative protocol also included three-dimensional fast-spin echo T 2 -weighted imaging and contrast-enhanced spoiled gradient-echo recalled imaging, both of which were used for surgical navigation in the operating room. In addition, dynamic contrast-enhanced susceptibility-weighted perfusion MR imaging (single-shot echo-planar gradient-echo imaging; TR 1250 msec, TE 54 msec, acquisition matrix 128 ϫ 128 pixels, section thickness 3-4 mm with no gap, FOV 26 ϫ 26 cm) was performed at preoperative and follow-up examinations but not during the immediately postoperative imaging session. The intravenous contrast material used for T 1 -weighted and dynamic contrast-enhanced susceptibility-weighted perfusion MR imaging consisted of gadopentetate dimeglumine (Omniscan; Amersham Health, Princeton, NJ) given at a dose of 0.1 mmol/kg of body weight. The immediately postoperative and follow-up MR imaging protocol also included unenhanced axial T 1 -weighted imaging (TR 600 msec, TE 9 msec, FOV 22 ϫ 22 cm, section thickness 5 mm with a 1-mm gap).
Image Analysis
The clinical interpretation of MR images was performed by various neuroradiologists. One neuroradiologist (S.C.) reviewed all studies and found no discrepancies regarding the presence or absence of diffusion-weighted imaging abnormalities. An abnormality on diffusion-weighted imaging was objectively defined as an area of reduced diffusion with an ADC value less than 500 ϫ 10 Ϫ6 mm 2 /second around or remote from the resection cavity. A thin linear rim of reduced diffusion around the resection cavity without a focal area of nodularity was not considered abnormal. Using inhouse software written in C and Matlab, manual segmentation was performed with region-of-interest analysis to measure volumes of both anatomical and diffusion abnormalities in cubic millimeters. For all patients, the volume of an abnormality on FLAIR imaging (defined as the entire le-sion, including both enhancing and nonenhancing components), edema (defined as a nonenhancing FLAIR imaging abnormality), tumor enhancement, and necrosis, were measured and compared with respective values on preoperative imaging. The postoperative diffusion territory and the subsequent area of encephalomalacia were qualitatively assessed using a computer workstation on which serial images could be viewed on one screen.
Clinical, Neuroimaging, and Surgical Parameters as Predictors of Postoperative Reduced Diffusion
Clinical, neuroimaging, and surgical data were collected for each patient and compared with the occurrence of postoperative reduced diffusion. The following clinical parameters were included: patient age and sex, tumor grade, tumor histological subtype, and the predominant anatomical location of the tumor. Neuroimaging data included the occurrence and volumes of the following: FLAIR imaging abnormality, edema, tumor enhancement, and tumor necrosis. The following surgical parameters were also included: surgeon, operating room time, duration of surgery, estimated blood loss, local versus general anesthesia, intraoperative fluid balance, intraoperative use of mannitol, and intraoperative use of a cotton ball soaked with H 2 O 2 (0.05%).
Statistical Analyses
Statistical analyses, including the Pearson chi-square test, Fisher exact test, and two-tailed t-test, were performed using SPSS version 11.5 (SSPS Inc., Chicago, IL). A probability value less than 0.05 was considered statistically significant. Data are presented as mean values Ϯ standard deviations.
Results
Patient Demographics and Tumor Characteristics
The patient population was composed of 44 patients with infiltrating gliomas (Table 1) , including 27 men and 17 women. The mean ages of the patients with Grades II, III, and IV tumors were 36.6, 47.9, and 52.4 years, respectively. The types of tumors harbored by these patients included 32 astrocytomas (nine Grade II, three Grade III, and 20 Grade IV lesions), eight oligodendrogliomas (seven Grade II tumors and one Grade III lesion), and four mixed oligoastrocytomas (two Grade II and two Grade III lesions). All tumors under investigation were supratentorial, with the majority of the lesions predominantly located in either the frontal or temporal lobe.
Preoperative Imaging Characteristics
The mean volumes of FLAIR imaging abnormalities, edema, tumor contrast enhancement, and tumor necrosis that were measured on preoperative images are shown in Table 1 . We observed the FLAIR imaging abnormality and edema to varying degrees in all lesions studied, and their respective means did not differ significantly among tumor grades (p = 0.31 and p = 0.44, respectively). The incidence of tumor enhancement and its volume when present were 11 (61) 2 (33) 21 (100) vol (cm 3 , mean Ϯ SD) § 3.9 Ϯ 7.9 1.1 Ϯ 1.0 18.9 Ϯ 11.5 tumor necrosis incidence, no. of cases (%)
* DWI = diffusion-weighted imaging; SD = standard deviation. † The volume of a FLAIR imaging abnormality is defined as the entire lesion, including both enhancing and nonenhancing components.
‡ The volume of edema is defined as a nonenhancing FLAIR imaging abnormality. § Mean and SD were calculated using only cases in which the imaging finding was demonstrated.
highest among Grade IV tumors (p Ͻ 0.0001), and the presence of necrosis was confined to Grade IV lesions. Diffuse tumor-associated reduced diffusion was identified on preoperative imaging in only three patients: two of whom harbored a Grade IV astrocytoma and one of whom had a Grade II oligodendroglioma. In all three cases, these areas of reduced diffusion were resected and thus were not evident on subsequent images.
Postoperative Diffusion-Weighted MR Imaging
Abnormalities on postoperative diffusion-weighted images were observed in 50% of the Grade II tumors, 100% of the Grade III tumors, and 65% of the Grade IV tumors (p = 0.09) ( Table 1) . Areas of reduced diffusion were typically nodular or fingerlike and, in all cases, appeared to be contiguous with the resection cavity. Each area demonstrated ADC values less than 500 ϫ 10 Ϫ6 mm 2 /second. Approximately one half of the postoperative abnormalities on diffusion-weighted imaging were identified in areas of residual nonresected T 2 signal abnormality, and the remaining abnormalities were located in areas of surrounding untreated normal-appearing brain. Preoperative and postoperative MR images for three representative cases in which reduced diffusion was identified postoperatively are shown in Figs. 1 to 3. These cases represent Grade II (Fig. 1 ), Grade III (Fig. 2) , and Grade IV (Fig. 3) lesions.
The course of each diffusion-weighted imaging abnormality on serial imaging studies is shown in Fig. 4 . Among the 28 cases in which a postoperative reduction in diffusion was demonstrated, the abnormality was observed to resolve in 25 cases (89%). On subsequent neuroimages the corresponding area exhibited contrast enhancement in each of these 25 cases, and in 24 of them (excluding Case 12), the enhancing region was ultimately replaced with a corresponding area of encephalomalacia (Fig. 4) . Notably, at the time of the last imaging study, in two (Cases 19 and 20) of the 25 cases partial replacement with encephalomalacia was observed at the site of the previous reduced diffusion, with the remainder of this site exhibiting persistent contrast enhancement.
The areas of postoperative reduced diffusion had not resolved at the time of the last imaging in Cases 14, 27, and 28 (Fig. 4) . On postoperative Day 148, the area of persistent reduced diffusion in Case 14 also demonstrated contrast enhancement. The patient in Case 27 underwent imaging for the last time on postoperative Day 91, at which time the original area of postoperative reduced diffusion had been partially replaced by an area of encephalomalacia, with the remaining area retaining its original diffusion-weighted imaging abnormality, without evidence of contrast enhancement. The area of postoperative reduced diffusion observed in Case 28 remained unchanged when it was last imaged on Day 244, at which point it did not demonstrate any evidence of contrast enhancement or encephalomalacia.
For the majority of cases, the postoperative reduced diffusion was documented to have resolved by the first follow-up neuroimaging study, usually within 3 months. The first documentation of contrast enhancement at a site corresponding to previous reduced diffusion was found in Cases 1 and 2 on postoperative Day 15, and enhancement was documented as late as postoperative Day 198 in Case 19 (Fig. 4) .
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Clinical, Neuroimaging, and Surgical Parameters
There were no statistically significant associations between the occurrence of a postoperative reduction in diffusion and the patient age or sex, tumor grade, tumor histological subtype, or predominant anatomical site of the tumor ( Table 2 ). Findings of a FLAIR imaging abnormality, edema, tumor enhancement, and tumor necrosis on preoperative images were also not significantly associated with the occurrence of postoperative reduced diffusion ( Table 2) .
The occurrence of a postoperative reduction in diffusion was also not predicted by any of the surgical parameters that were evaluated, including the surgeon, operating room time, duration of surgery, estimated blood loss, local compared with general anesthesia, intraoperative fluid balance, intraoperative use of mannitol, and intraoperative use of cotton balls soaked with H 2 O 2 (Table 3) . In all five cases in which a cotton ball with H 2 O 2 had been used in the operating room, reduced diffusion in the resection cavity was demonstrated postoperatively. This association was not statistically significant because a cotton ball containing H 2 O 2 was not used in the vast majority of cases with postoperative reduced diffusion. Thus, no clear causative role may be attributed to the use of a cotton ball based on these data alone. There were no intraoperative complications or documented periods of significant intraoperative hypotension or hypoxia in any case in this series.
Discussion
Management of infiltrating glioma frequently involves resection, which may be followed by adjuvant therapies including external-beam radiation therapy and chemotherapy. 3 Neuroimages are typically obtained immediately postoperatively in these patients and provide a new baseline on which to compare future neuroimages. Subsequent imaging studies serve a critical role in the assessment of tumor behavior. Evidence of new contrast enhancement on these studies signals tumor recurrence or progression and frequently prompts more aggressive therapies, which are attended by higher risks of morbidity.
Diffusion-weighted imaging is not currently part of standard reference imaging for patients with gliomas. Based on our observations of reduced diffusion abnormalities on immediately postoperative diffusion-weighted images, we have prospectively investigated the occurrence, time course, and outcome of these abnormalities in a series of 44 patients with infiltrating gliomas, who presented for initial surgical management of the disease and underwent serial neuroimaging. We have demonstrated that reduced diffusion abnormalities adjacent to the surgical resection cavity were present in approximately two thirds of the cases on the immediate postoperative images and that the vast majority of these abnormalities underwent a predictable progression from contrast enhancement to demonstration of encephalomalacia. If diffusion-weighted MR imaging is not obtained immediately postoperatively, these areas of presumed tissue injury cannot be distinguished from a tumor recurrence during the time period in which they demonstrate contrast enhancement. Accordingly, the findings of our study strongly indicate that it is essential to obtain diffusion-weighted images immediately postoperatively for all patients with infiltrating gliomas who undergo tumor resection, and that this mode of imaging provides important information for the interpretation of subsequent follow-up MR images in these patients.
Both cortical and subcortical areas of reduced diffusion were observed after surgery. Reduced diffusion in cortical areas may be associated with surgical technique. We generally resect infiltrating gliomas through corticectomy, instead of through a linear cortical incision. Corticectomy disrupts the blood supply of the resected cortex and the immediate surrounding areas. Subcortical areas of reduced diffusion may be due to the interruption of small medullary arteries and veins.
Gelfoam was routinely used for hemostasis but was not left in the surgical cavity at the completion of the surgical procedure. Although resection cavities were routinely lined with Surgicel, there were no imaging findings that could be attributed to this material. The specific pattern of delayed contrast enhancement described in this report was always preceded by a corresponding area of restricted diffusion. The use of Surgicel in the resection cavity has not been reported to cause restricted diffusion, and, based on the inconsistent occurrence and typical pattern of postoperative restricted diffusion shown in the present study, we cannot suggest such an association either.
Complete resolution of a postoperative region of reduced diffusion was demonstrated within 90 days after surgery in 24 of the 28 patients. The time course for resolution of this abnormality, however, was dependent on the interval between the immediate postoperative MR imaging study and the first follow-up study. For the majority of these patients, the abnormality on diffusion-weighted imaging had resolved by the first follow-up MR imaging study. In four patients, however, there was evidence of prolonged reduced diffusion, ranging from 91 to 244 days after surgery. For these patients, the corresponding ADC ratios continued to be abnormally low, indicating that these areas did not represent a "T 2 shine through." The amount of time required for the reduced diffusion to resolve and the ADC ratio to return to normal in patients with gliomas has not been well 10 performed a similar analysis and reported pseudonormalization within 9 days. Nevertheless, other researchers have identified stroke cases in which the ADC ratio did not pseudonormalize until up to 1 month after symptom onset. 28, 29 The reason for the prolonged reduced diffusion in a subset of our patients remains unclear. It is possible that in these patients the brain areas contained cells partially devascularized by the surgical procedure, which persisted in a state of ischemia or venous congestion.
Although several potential applications of diffusionweighted MR imaging in patients with gliomas have been investigated, its role in the immediate postoperative period has not been previously reported. 35 Chenevert and colleagues 7 demonstrated the ability of diffusion-weighted imaging to serve as an early marker tool for quantification of the chemotherapy response in orthotopic rat brain tumors derived from implanted rat 9L glioma cells. Diffusionweighted MR imaging has been successfully used to distinguish high-grade astrocytomas from cerebral metastases and from cerebral lymphomas.
11, 19 Lidar, et al., 21 used this mode of imaging in patients with malignant gliomas to assess the extent of convection-enhanced delivery of paclitaxel therapy, and authors of recent reports have stated that diffusion-weighted imaging may be useful in differentiating tumor recurrence from radiation injury. 4, 13, 26 There appears to be no advantage of diffusion-weighted imaging over conventional MR imaging for the assessment of tumor extension because the contrast between tumor and white matter is typically lower in the former. 31 The ADC, a calculated value based on diffusion-weighted imaging, has been shown to correlate with the degree of tissue cellularity and thus may help distinguish between low-and high-grade lesions; nevertheless, there is often a significant overlap in ADC values between these two groups. 5, 6, 18, 20, 32 Multiple clinical, neuroimaging, histological, and surgical parameters were assessed to identify an association with a postoperative reduction in diffusion; however, none of the evaluated factors demonstrated a statistically significant association. Notably, no significant associations were identified when the incidence of postoperative reduced diffusion was stratified based on the operating surgeon. Cotton balls are used in the brain by some surgeons to aid in hemostasis. In all five cases in which an H 2 O 2 -soaked cotton ball was used, postoperative reduced diffusion appeared in the resection cavity. No clear causative role can be attributed to the cotton ball-H 2 O 2 combination based on these data alone, however, because it was not used in the vast majority of cases in which postoperative abnormalities were identified on diffusion-weighted images.
Although new enhancement is of greater concern in a high-grade lesion than in a low-grade neoplasm, the current reference standard used to assess tumor recurrence is based on contrast-enhanced imaging, regardless of whether the tumor is low or high grade. Although gross-total resection was achieved in all cases of low-grade tumor presented in this report, the presence of new enhancement in residual tumor, even in cases of low-grade lesions, would be of concern for the recurrence or progression of the disease. In addition, given that histological findings in infiltrative glioma are subject to a sampling error that may favor undergrading of lesions, higher-grade components may be present in lesions that are diagnosed as low-grade lesions based on the histological findings.
Based on a review of additional follow-up images obtained in the 28 patients with postoperative diffusionweighted imaging abnormalities, none of the low-grade lesions have demonstrated recurrence to date. The majority of high-grade lesions have progressed; however, we have not identified any cases in which the tumor recurred in the same region as the abnormality identified on diffusion-weighted images obtained immediately postoperatively (data not shown).
Conclusions
An abnormality on diffusion-weighted MR imaging obtained immediately postoperatively was not infrequently identified after resection of newly diagnosed infiltrating gliomas, occurring in 64% of the cases studied. The abnormality typically resolved; it was replaced by contrast enhancement on follow-up images and, ultimately, by the appearance of encephalomalacia on long-term follow-up studies. Findings on neuroimages obtained during the period of enhancement could be confused with the appearance of recurrent tumor and interpreted as an early treatment failure, prompting treatment with salvage and trial therapies. The findings of our study strongly indicate that it is essential to perform diffusion-weighted MR imaging immediately after surgery and MR imaging immediately prior to the initiation of radiotherapy to monitor disease progression. New contrast enhancement observed on neuroimages following glioma surgery should be interpreted in the context of the immediately postoperative diffusion-weighted images.
